EGFR and cancer: Dysfunctional EGFR signaling promotes the acquisition of cancer stem-like properties, including self-renewal, tumor heterogeneity, metastasis, resistance to chemotherapy and radiotherapy, and recurrence, by increasing the expression of CSC-related markers in NSCLC [32,33,34].